Trials / Completed
CompletedNCT02416258
A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)
A Phase 2a Trial Evaluating the Anti-psoriatic Effect of LP0113 Aerosol Spray Compared With Its Vehicle and With Daivobet® Gel, LEO 90100 Aerosol Foam, Betamethasone Dipropionate Aerosol Spray and Calcipotriol Aerosol Spray in the Treatment of Psoriasis Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the anti-psoriatic effect of LP0113 aerosol spray compared to Daivobet® gel, LEO 90100 aerosol foam, betamethasone dipropionate in the aerosol spray vehicle, calcipotriol in the aerosol spray vehicle and aerosol spray vehicle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LP0113 aerosol spray | |
| DRUG | Aerosol spray vehicle | |
| DRUG | LEO 90100 aerosol foam | |
| DRUG | Betamethasone dipropionate aerosol spray | |
| DRUG | Calcipotriol aerosol spray | |
| DRUG | Daivobet® gel |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2015-04-14
- Last updated
- 2025-02-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02416258. Inclusion in this directory is not an endorsement.